United States
Germany
Japan
United Kingdom
China
Anti-IL-6 / IFNb2 Reference Antibody (Chugai SK2)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Antibodies
Anti-IL-6 / IFNb2 Reference Antibody (elsilimomab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque |
Anti-IL-6 / IFNb2 Reference Antibody (olokizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-IL-6 / IFNb2 Reference Antibody (sirukumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-6 / IFNb2 Reference Antibody (MEDI 5117)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IL-6 / IFNb2 Reference Antibody (siltuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-6 / IFNb2 Reference Antibody (CSTRI patent anti-IL-6)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-6 / IFNb2 Reference Antibody (Medarex patent anti-IL-6)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IL-6 / IFNb2 Reference Antibody (Merck patent anti-IL-6)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-6 / IFNb2 Reference Antibody (clazakizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
Anti-IL-6 / IFNb2 Reference Antibody (ziltivekimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
